All News

Watch the @RheumNow #rheumatoidarthritis panel discuss some of our highlights from #ACR21! https://t.co/Q5Yps3s165

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

Do watch the Autoinflammatory Faculty @RheumNow discussed a selection of data presented at #ACR21 @uptoTate @bella_mehta @DrPetryna Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of labs in i... https://t.co/4biuKzWLBc via @YouTube

Links:

Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)

Impromptu #TeamSparks video meeting with 2nd year fellows @KronzerMD and Dr Gregory McDermott detailing our research findings from the @MassGenBrigham Biobank (funded by @NIH_NIAMS and VERITY) @OrACORe_BWH @MayoClinic @RheumNow #ACR21 https://t.co/CQ9XDamb0E

Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)

So I think the talk of #ACR21 has been ORAL Surveillance, the phase 3b/4 @US_FDA post-marketing requirement study of tofacitinib vs TNFi in CV risk pts. I've tried to capture this live through a few threads/tweets, as it happened. Catch up via this thread of threads @RheumNow

David Liew drdavidliew ( View Tweet)

Dr. Aurelie Nahm ( @AurelieRheumo) shares #ACR21 presentation findings on TNF inhibitors and radiographic progression in axSpA https://t.co/FPs43SGH5R https://t.co/MeM1Js5p4n

Links:

Dr. John Cush RheumNow ( View Tweet)
Sinusitis and Pharyngitis with Incident RA: Dr. Richard Conway discusses abstract #0564 presented at the #ACR21 annual meeting. https://t.co/rWS8VT5obl https://t.co/cHLTf9HPWe

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow’s expanded coverage of the #ACR21 Annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.

Dr. John Cush RheumNow ( View Tweet)

Drug retention of TNFi vs. secukinumab in AxSpA pts Abs#911 ⭐️46% discontinued either treatment ⭐️TNFi with slightly better drug retention ⭐️Age, BASDAI, BMI did not favor any group ⭐️inefficacy - main reason #ACR21 @RheumNow https://t.co/ynoomYrTvX
Robert B Chao, MD doctorRBC ( View Tweet)
📢No difference in ESRD or mortality with RTX-based vs CYC-based induction regimen in ANCA #Vasculitis #ACR21 https://t.co/Bdz5t2uyHi
Guy Katz, MD GuyKatzMD ( View Tweet)
#ACR21 #ACR2021 Extra pulmonary sarcoidosis ➡️ Cutaneous Sarcoidosis 👌🏻 talk not posting a tweetorial for the talk as I would suggest go see the talk once masterclass in Cutaneous sarcoidosis https://t.co/vkWXkq7DXF
EnvisionRheumat ERheumat ( View Tweet)
🎉 To celebrate the start of #ACR21, I'm happy to share this slide about #autoantibodies in systemic #autoimmune diseases such as #lupus, sjogren, systemic sclerosis, myosotis...and their main targets 🎯 As you may guess this took me a few hours to assemble... https://t.co/fNmgfOFbiD
Laurent ARNAUD Lupusreference ( View Tweet)
Treatment for VEXAS syndrome. It is steroid responsive. Avoid IL-1 inhibitors severe skin reactions at injection site, bone marrow transplant may be curative @RheumNow #ACR21 Session6S410 L Wilson, DO Cordona https://t.co/eQ1KVDiKKV
Dr. Antoni Chan synovialjoints ( View Tweet)
Love this COVID ARDS risk calculator put forth by @JYazdanyMD at #ACR21 for our patient's with Rheumatic Diseases. A wonderful resource in talking to our patients about vaccine necessity! @CleClinicMD https://t.co/EA5jVYweHm
Emily Littlejohn ELittlejohnDO ( View Tweet)
#ACR21 #ACR2021 Clinical Pearls 🚨 Thread Alert 1/n 💥AAV does not typically cause hard palate lesions➡️consider: Cocaine induced midline destructive lesion(HNE+)/Malignancy 💥Limited GPA can be ANCA negetive in 50% 💥 oral cavity examination is a must in Rheum https://t.co/RxkLiGdcJt
EnvisionRheumat ERheumat ( View Tweet)
#ACR21 #ACR2021 Sjogrens syndrome with pulmonary involvement guidelines 🚨Thread Alert 👉🏻Screen all patients for pulm inv. irrespective of symtopms ➡️ prevlance of lung involvement can be upto 65% 👉🏻Complete PFT includes ➡️ Spirometry➕ DLCO➕ PuseOximetry https://t.co/prFgQESRyF
EnvisionRheumat ERheumat ( View Tweet)
Targeting the HUGE dilemma!🎯 #Psoriatic vs Erosive #OA PsA 👉 Fluffy bone formation(enthesitis of phalanges) 👉 Marginal erosions(vs central) 👉 Many jts in same digit(ray inv) 👉 Periarticular SOFT tissue swelling (dactylitis). 👉 NOT much hand OA #ACR21 RadiologyBootCamp https://t.co/OQLPoeRLny
Ashima Makol MD AshimaMakol ( View Tweet)
Live from #ACR21: Learning about osteoarthritis from Dr. Marc Hochberg. "Don't use the term degenerative joint disease." -much more involved. I like this figure of the multiple different phenotypes. #ACRAmbassador https://t.co/UwU4vCmYXa
Jilaine Bolek Berquist BolekBerqui ( View Tweet)
#ACR21 The Great Debate: Belimumab vs Voclosporin as Add-On Therapy in #LupusNephritis | Dr. Petri & Dr. Rovin Audience Vote 🗳: What would you add to mycophenolate first? Belimumab 71%, Voclosporin 29% #ACRAmbassador @ACRheum Summary of Pros & Cons of Each⬇️ https://t.co/OtLxs8IYr9
Mithu Maheswaranathan, MD MithuRheum ( View Tweet)
#ACR21 TM24. Hydralazine-induced ANCA vasculitis presenting with chondritis. Labs: +ANA +Anti-histone +p-ANCA, +MPO and +PR3 @Rheumnow https://t.co/YQvqj0vCHp https://t.co/LPyVYYzLtI

Links:

Eric Dein ericdeinmd ( View Tweet)
#ACR21 2022 ACR/EULAR GPA Criteria ▶️Classification, NOT diagnostic! ⭐️Clinical, lab, imaging, and biopsy criteria ⭐️+5 pts for cANCA or PR3, negative pts for pANCA or MPO, or eosinophilia @RheumNow https://t.co/6YWmabNzuH https://t.co/vg8zaFt5dR

Links:

Eric Dein ericdeinmd ( View Tweet)
×